SEBIO ANNOUNCES WINNERS OF SECOND ANNUAL AWARDS CEREMONY TO

							December 18, 2008

SEBIO ANNOUNCES WINNERS OF SECOND ANNUAL AWARDS
CEREMONY TO HONOR THE TOP REGIONAL DEALS OF THE YEAR
Atlanta, GA-SEBIO announced four winners of the Second Annual SEBIO Awards in a ceremony held at
its Tenth Anniversary Investor Forum in Palm Beach, FL on December 5th. The awards honored
companies in the following categories: Southeast (SE) Deal of the Year: Initial Funding; SE Deal of the
Year: Venture Capital Transaction and SE Deal of the Year: Strategic Transaction. In addition, the
organization awarded its SE Leadership Award to an individual or organization that made a notable
contribution to the growth of the life sciences industry in the region over the last year. The winners
were ViewRay, Inc., Biolex, Inc., Serenex, Inc., and Rebecca Kaufman of King & Spalding, respectively.

“Our SEBIO Annual Awards recognize those companies and individuals that are driving the growth of the
region's life sciences industry,” said former SEBIO Chair Phillip Street, a partner with Kilpatrick Stockton.
“We wanted to continue to highlight the success of our Investor Forum graduates, many of whom have
gone on to raise substantial venture capital rounds, to partner with big pharma, and in many cases, to
go public. These success stories show the maturation of the industry in our region and reflect very well
on what is happening here to those who have an interest in getting to know our region a little better.
The SEBIO Leadership Award, in particular, is a great way to highlight the role of individuals who really
distinguish themselves by their unique contribution to our industry.”

“The recipients of the awards have achieved outstanding success in 2008 and it’s a pleasure to honor
them,” said SEBIO 2008 Awards Committee Chair Garheng Kong, Intersouth Partners. “We have high
hopes for them in the future and believe that these companies are an example of the numerous strong
companies we have in the Southeast.”

Viewray, Inc. won the SE Deal of the Year: Initial Funding Award. Viewray was honored for its $25
million financing in January. The financing was led by OrbiMed Advisors and Fidelity Biosciences, and
was joined by Aisling Capital, and Kearny Venture Partners. ViewRay is focused on the development of a
real-time magnetic resonance imaging (MRI) guided radiation therapy device for the treatment of
cancer patients.

Biolex, Inc. won the SE Deal of the Year: Venture Capital Transaction Award. Biolex was honored for its
$60 million Series D financing in October. Leading the financing was Clarus Ventures with OrbiMed
Advisors participating as a new investor. Existing investors participating in the financing included
Intersouth Partners, Quaker BioVentures, Johnson & Johnson Development Corporation, Investor
Growth Capital, Polaris Ventures, Mitsui & Company, The Dow Chemical Company, JP Morgan Securities
and the North Carolina Economic Development Fund. Biolex is a clinical-stage biopharmaceutical
company that uses its patented LEX SystemSM to develop hard-to-make therapeutic proteins and to
optimize monoclonal antibodies. The Company’s lead drug candidate is Locteron, a controlled-release
interferon alfa designed to improve patient care in the treatment of hepatitis C through a more
favorable side-effect profile and dosing convenience compared to existing pegylated interferon
products.

Serenex, Inc. won the SE Deal of the Year: Strategic Transaction for its strategic alliance with Pfizer, Inc.
Pfizer acquired cancer treatment developer Serenex, a seven-year-old company that raised $81 million
in equity over its life. Pfizer acquired the rights to Serenex' lead compound, oral Hsp90 inhibitor SNX-
5422, currently in Phase I trials for solid tumors and hematological malignancies. In addition, Pfizer also
acquired Serenex' drug discovery technology and its small molecule Hsp90 inhibitor compound library,
including targets for cancer, inflammatory and neurodegenerative diseases. The terms of the deal were
not disclosed.

 Becky Kaufman, partner with King & Spalding, was honored for the SE Leadership Award. Becky was
recognized for her incredible devotion to the organization for the past ten years. For the majority of the
past ten years, SEBIO was an all-volunteer organization, with no paid staff, Becky has been described as
the “glue” that held things together year after year. She has served many roles, including Chair of the
Investor Forum (2005), Chair of SEBIO (2007) and, currently, Chair of the Marketing Committee.

The Third Annual SEBIO Awards Ceremony will be held during the 2009 Southeastern BIO Investor
Forum on December 3-4, 2009, at the Charleston Place in Charleston, SC. Further details will be posted
on the SEBIO web site.